TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05947656: An Open-label, Non-randomized, Single-arm Pilot Study to Evaluate the Safety and Efficacy of Multiple Pulsed Focused Ultrasound Treatment in Patients With Drug Resistant Temporal Lobe Epilepsy

Sponsor: Genovate-NaviFUS (Australia) Pty Ltd. · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 20 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$9,544,800

Rescue Site Savings

+$6,285,600

Unlock Full NCT05947656 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05947656 Rescue Dossier →